Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study

J Antimicrob Chemother. 2016 Dec;71(12):3621-3622. doi: 10.1093/jac/dkw306. Epub 2016 Aug 3.

¹ Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
² Division of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
³ Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy al.bor86@gmail.com.
⁴ Department of Medical Biotechnologies, University of Siena, Viale Bracci 16, 53100 Siena, Italy.
⁵ University Division of Infectious Diseases, Hospital Department of Specialized and Internal Medicine, Viale Bracci 16, 53100 Siena, Italy.

No abstract available

Publication types